Biotechnology Forums

Full Version: Manufacture of vascular smooth muscle cells from the patient's skin
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
Scientists create cells constitute the vascular wall; this study may lead to new LYVE1 treatments for cardiovascular disease and better screening methods. Cambridge University scientists have for the first time with the patient's skin cells to produce different types of vascular smooth muscle cells (of SMCs, constitute the cells of the blood vessel wall).The study was partially funded by the Wellcome Trust, the findings in the June 13 published in "Nature - Biotechnology" (Nature Biotechnology).1/3 in the UK, the total number of LYZ deaths due to cardiovascular disease. Most of which is due to atherosclerosis caused by a blood vessel in the "scale" and embolism. For those patients not suitable for traditional stents or bypass treatment, an option in the future may grow new blood vessels to bypass their own blocked blood vessels.Corresponding author of the MAD2 study, the Wellcome Trust Intermediate Fellow of the University of Cambridge, Dr. Sanjay Sinha, said: "This study represents an important step, will have the ability to create the correct type of smooth muscle cells use to build new blood vessels. Other patients may benefit from these new blood vessels, including those in need of vascular grafts for dialysis patients with renal failure.In the study, scientists used embryonic MAD2L stem cells (or similar cells derived from skin samples of patients), they have the potential to form various types of body cells are called pluripotent cells (hPSCs). The use of human pluripotent stem cells (hPSCs), they found a method of manufacturing high purity vascular smooth muscle. Before employing more than capable cells (hPSCs) to produce blood cells and myocardial cells, this study is the 1BP first time in a system developed out of the main types of vascular smooth muscle cells, and this system can easily scale for clinical level of production.

Vascular smooth muscle cells derived from different tissues in the early embryo, scientists have been able to reproduce the three different types of embryonic tissue in a dish. Interestingly, these smooth muscle cells (SMCs), the response of the material (such as growth factors) can lead to vascular Madcam1 disease vary, depending on which they are the source of embryonic way. They concluded that the embryonic origin of the differences may determine some of the common vascular diseases (such as aortic aneurysm or atherosclerosis, etc.) played a part in when and where to form. Sinha added: "Using this system, we can begin to understand the origin of the smooth muscle cells (SMCs) is how to affect the development of vascular disease and why the blood vessels in some areas to be protected against the disease affects.""In addition, there are many patients suffering from a hereditary disease (such as Marfan syndrome), it affects the vascular smooth muscle cells and lead to premature cell death and disability. Through this study, the use of manufacturing by the patient skin samples pluripotent stem cells (hPSCs), we will be able to in a lab dish to create a disease carry a genetic abnormality smooth muscle cells. such 'plates' model will allow us to better understand the disease and allows us to filter some new method of treatment. "
Latest discoveries in the tissue engineering field: “Cyborg tissue”

Tissue engineering is usually dealing with living cells, artificial materials and strong knowledge of organ/tissue physiology & histology when creating a replacement for the dysfunctional organ. Every organ has more or less complicated structure that is vital for its proper functioning. Designing exact replica is not the most complicated part of the tissue engineering (with modern technology and wide anatomical knowledge we have today). The biggest problem with artificial organs lays in the fact that scientist are lacking information on its functioning when inserted back to the body. So far there wasn’t non-invasive method to monitor the cellular behavior and adjustment after tissue transplantation.

However, as with every other medical field, one that is dealing with artificial tissue and organ development is constantly improving. “Cyborg tissue” is latest discovery in this area, where living cells are incorporated into specific nano-wires designed 3D network. Research team from the Boston Children's Hospital and Harvard and Massachusetts University joined together to created a 3D nanoscale scaffold where cells are planted and integrated in one functional system.

Until now, interaction between cells or their individual activity was measured using electrodes, but this method is aggressive and result in cell injury. Main goal of this study was to create a tissue where electronic part will be merged will living part of the tissue, enabling scientist to follow all changes without damaging the cells or disrupting their biological activity. Every biochemical process in the organism is a result of the well organized and controlled cascade of chemical and electronic impulses that are traveling from one part of the body to another, from one cell to a sometimes very distant one. Autonomic nervous system is responsible for maintaining homeostasis in the organism. It is keeping all this processes under control by coordinating complicated cellular signals and cascade events. When artificial tissue is inserted in the body, it can’t recognize the signals body is emitting and as a result it never becomes truly “accepted” and functional part of the body. “Perfect” artificial tissue would be able to mimic intrinsic feedback loops in the body and establish control in the tissue functioning by recognizing and adapting to the chemical signals send by other cells in the body, such as hormones, neurotransmitters or respond to the changes in the pH, oxygen level…. Other important thing scientist had in mind was to a create tissue whose cellular activity would be easily monitored and/or stimulated.

Previous attempts to create bio-engineered sensing networks combining electronics with living cells were focused on 2D models, where cell were growing on the top of the electronic component. Since specific tissue architecture is one of the most important things for normal functioning, creating 3D model is what finally brought success. Newly designed model has a structure like a cotton candy, where silicon wires with ~80 nm in diameter are forming mesh like network or can be shaped like flat planes. Organic polymer is placed around nanoscale wires. Miniature electrodes are connecting wire elements in the mesh allowing nanowire transistors to detect cellular activity without inflicting damage. Pores of this reticular model are big enough and cells could grow freely once they are seeded in this 3D mesh.

Using the heart and nervous tissue cells, artificial tissues with embedded nanoscale networks were created without disrupting cellular structure and functioning. Scientists are able for the first time to track all electronic signals generated by the cells using nano-scale networks. They could also monitor changes in the cellular communication after applying cardio- or neurostimulating drugs.

Besides cardiac and neural tissue, artificial blood vessel with embedded nanoscale networks is created as well. Goal was to design a tissue that could be able to recognize changes in the pH both in- and outside the vessel. Those changes are happening during ischemia and inflammation and early recognition of the potential danger and instant reaction is sometimes essential for the survival.

Application of the newly designed 3D synthetic biomaterial is wide. Scientists could stimulate and monitor cellular interaction without affecting their viability. Pharmaceutical industry could benefit from this model as well; 3D tissue could give a better insight into drug reaction and cellular response than conventional two layer cell culture.